Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)
Clinical trial NCT03336502 · COMPLETED
Trial details
- NCT number
- NCT03336502
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2018-11-26
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.